tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ANIK is currently covered by 1 analysts with an average price target of $23.24. This is a potential upside of $9.12 (64.59%) from yesterday's end of day stock price of $14.12.
Anika Therapeutics's activity chart (see below) currently has 39 price targets and 34 ratings on display. The stock rating distribution of ANIK is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 32.42% with an average time for these price targets to be met of 40.8 days.
Highest price target for ANIK is $17, Lowest price target is $17, average price target is $17.
Most recent stock forecast was given by MICHAEL PETUSKY from BARRINGTON on 27-Feb-2026. First documented stock forecast 28-Dec-2017.
Currently out of the existing stock ratings of ANIK, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Aug-2023
$17
$4.21 (32.92%)
$16
7 days ago
(27-Feb-2026)
10/22 (45.45%)
$4.21 (32.92%)
110
Buy Since 21-Jan-2020
$32
$19.21 (150.20%)
$61
2 years 6 months 25 days ago
(09-Aug-2023)
1/3 (33.33%)
$11.99 (59.92%)
73
Buy Since 15-Nov-2021
$35
$24.79 (242.80%)
$55
3 years 11 months 25 days ago
(09-Mar-2022)
0/2 (0%)
$8.78 (33.49%)
Hold Since 16-Jul-2021
$46
$33.21 (259.66%)
$46
4 years 3 months 16 days ago
(18-Nov-2021)
0/2 (0%)
$5.44 (13.41%)
Buy Since 23-Sep-2019
$65
$52.21 (408.21%)
$54
6 years 1 months 24 days ago
(10-Jan-2020)
5/6 (83.33%)
$15.2 (30.52%)
21
What is ANIK (Anika Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ANIK (Anika Therapeutics) with a proven track record?
Which analyst has the current lower performing score on ANIK (Anika Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ANIK (Anika Therapeutics)?
Which analyst is the currently most bullish on ANIK (Anika Therapeutics)?
Which analyst is the currently most reserved on ANIK (Anika Therapeutics)?
